BCL2L1 and pancreatic adenocarcinoma: Finally, 8 differentially expressed genes (ERLIN1, HMGA2, FAM110B, EGFR, MCM2, BCL2L1, E2F1 and RAC1) were considered to be significantly negatively associated with survival (P < 0.05) time of pancreatic adenocarcinoma patients.